Dr Salim Shafeek

Dr Salim Shafeek, MD FRCP FRCP(Ed) FRCPath (Haem) Consultant Haematologist | Hon. Senior Lecturer, University of Birmingham | Former Clinical Director, Haemato-Oncology (Worcestershire Oncology Centre) PROFESSIONAL SUMMARY Senior Consultant Haematologist with over 20 years’ experience in haemato-oncology, clinical leadership, and research. Former Clinical Director leading centralisation of countywide cancer services and establishing the Worcestershire Oncology Centre. Principal Investigator for multiple NCRI trials (AML, ALL, Myeloma, CLL, Lymphoma), with strong academic links to the University of Birmingham. National examiner for MRCP(UK) and FRCPath, recognised with multiple patient choice and leadership awards. CURRENT ROLES Consultant Haematologist, Worcestershire Acute NHS Trust (2005–present) - Lead for haemato-oncology across Worcestershire. - Principal Investigator for >12 NCRI/industry trials. - Developed acute oncology service and nurse-led anticoagulation clinics. Hon Senior Lecturer, University of Birmingham (2008–present) - Curriculum lead for MBChB haemato-oncology module. - Examiner for MRCP(UK) PACES and FRCPath. Former Clinical Director, Haemato-Oncology (2009–2021) - Oversaw service expansion to 7 consultants and CNS network. - Established Worcestershire Oncology Centre, first twin unit in UK. EDUCATION & QUALIFICATIONS MBBS, Trivandrum Medical College (1989) – First Class, 4th Rank University MD (General Medicine), Calicut University (1992) – 1st Rank, Gold Medal MRCP(UK) (1994), DipRCPath (1997), FRCPath Haematology (1998) FRCP(Edin) & FRCP(London) (2004) DISTINCTIONS & AWARDS G.K. Warrier Memorial Gold Medal – First Rank in MD Medicine (1992) Best Outgoing Postgraduate, University of Calicut (1992) Patient Choice Award, Worcestershire Acute NHS Trust (2022 & 2023) Chairman’s Special Award for Charity & Patient Care (2023) RESEARCH & ACADEMIC CONTRIBUTIONS Principal Investigator for NCRI trials: AML18/19, UKALL14, Myeloma XI–XII, FITNESS, FLAIR, RIALTO, RADAR, PACIFICO, RATHL, ReMODEL-B, VICTOR. Recruitment leader – 7th nationally in Myeloma XI trial. Member, UK Myeloma Bone Disease Guideline Committee (2025). Published and presented extensively in national/international forums. TEACHING & EXAMINING Lead trainer for Haemato-Oncology, University of Birmingham MBChB. Faculty, MSc Haematology (University of Birmingham, since 2002). Examiner, MRCP(UK) PACES & FRCPath final examinations. Host centre for FRCPath Final Examination, Worcestershire. PROFESSIONAL MEMBERSHIPS British Society for Haematology | American Society of Haematology | Royal Colleges of Physicians (London, Edinburgh) | Royal College of Pathologists REFERENCES Available on request

Myeloma , Lymphoma , Chronic Leukaemia , Myeloproliferative disorder , Thrombosis , Haemostasis, Anaemia , Iron infusions